Chart calendar Heron Therapeutics Inc
Upcoming events on Heron Therapeutics Inc
Past events on Heron Therapeutics Inc
2024-06-13 09:00 | Annual General Meeting |
2024-05-15 09:30 | Investor Day |
2024-05-07 08:30 | Q1 2024 Earnings Call |
2024-05-07 08:00 | Q1 2024 Earnings Release |
2024-04-10 11:00 | Needham Healthcare Conference |
2024-03-12 16:30 | Q4 2023 Earnings Call |
2024-03-12 16:05 | Q4 2023 Earnings Release |
2023-11-14 16:30 | Q3 2023 Earnings Call |
2023-11-14 16:05 | Q3 2023 Earnings Release |
2023-09-18 | Northland Capital Markets Institutional Investor Conference |
2023-08-14 16:30 | Q2 2023 Earnings Call |
2023-08-14 16:05 | Q2 2023 Earnings Release |
2023-06-07 | Annual General Meeting |
2023-05-11 16:30 | Q1 2023 Earnings Call |
2023-05-11 16:01 | Q1 2023 Earnings Release |
2023-04-20 11:45 | Needham Healthcare Conference |
2023-03-23 16:30 | Q4 2022 Earnings Call |
2023-03-23 16:05 | Q4 2022 Earnings Release |
2023-03-07 14:10 | Cowen Health Care Conference |
2022-12-01 10:05 | Evercore ISI HealthCONX Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 146 142 2.84% | 88,6 87,4 1.41% | 86,3 91,8 -5.98% | 108 105 2.63% | 127 124 2.8% | 148 |
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -225 -177 -27.3% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -211 -202 -4.2% | -228 -220 -3.56% | -218 -223 2.12% | -175 -191 8.77% | -111 -124 10.97% | -15,4 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -205 -197 -4.12% | -227 -224 -1.41% | -221 -225 1.82% | -182 -197 7.6% | -111 -124 11% | -14,3 |
Net income Million USD | Released Forecast Spread | -205 -198 -3.67% | -227 -224 -1.41% | -221 -225 1.82% | -182 -197 7.6% | -111 -121 8.42% | -14,3 |
EPS USD | Released Forecast Spread | -2,50 -2,40 -4.34% | -2,50 -2,47 -1.33% | -2,24 -2,28 1.9% | -1,67 -1,85 9.63% | -0,80 -0,93 13.67% | -0,09 |
Announcement Date | 02/03/20 | 24/02/21 | 28/02/22 | 23/03/23 | 12/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 23,5 22,6 3.76% | 27,6 24,7 12.08% | 26,6 27,0 -1.49% | 30,0 27,2 10.24% | 29,6 29,7 -0.24% | 31,8 31,7 0.21% | 31,4 31,8 -1.25% | 34,2 31,2 9.66% | 34,7 33,0 5.14% | 35,9 | 36,9 | 40,4 |
EBIT Million USD | Released Forecast Spread | -62,9 -48,4 -30.11% | -49,5 -51,1 3.19% | -41,9 -42,1 0.46% | -20,4 -37,1 45.21% | -33,1 -23,7 -39.77% | -42,4 -27,8 -52.65% | -24,9 -38,2 34.73% | -10,2 -23,4 56.36% | -4,80 -10,9 55.85% | -5,24 | -4,00 | -1,37 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -63,9 -48,8 -30.96% | -56,4 -52,4 -7.6% | -41,9 -44,1 5% | -19,9 -36,1 45.03% | -32,8 -24,0 -36.29% | -42,1 -28,3 -48.76% | -25,0 -38,0 34.13% | -10,7 -24,0 55.29% | -3,16 -10,7 70.36% | -5,30 | -3,90 | -1,50 |
Net income Million USD | Released Forecast Spread | -63,9 -48,8 -30.96% | -56,4 -52,4 -7.6% | -41,9 -44,1 5% | -19,9 -36,1 45.03% | -32,8 -24,0 -36.29% | -42,1 -28,3 -48.76% | -25,0 -38,0 34.13% | -10,7 -24,0 55.29% | -3,16 -10,7 70.36% | -5,30 | -3,90 | -1,50 |
EPS USD | Released Forecast Spread | -0,63 -0,48 -32.35% | -0,55 -0,50 -9.13% | -0,38 -0,38 -1.06% | -0,17 -0,32 46.2% | -0,27 -0,20 -33.33% | -0,35 -0,23 -49.57% | -0,17 -0,31 45.74% | -0,07 -0,16 57.14% | -0,02 -0,07 71.43% | -0,04 | -0,03 | -0,01 |
Announcement Date | 09/05/22 | 09/08/22 | 08/11/22 | 23/03/23 | 11/05/23 | 14/08/23 | 14/11/23 | 12/03/24 | 07/05/24 | - | - | - |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release |
2024-07-22 07:00 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release |
2024-07-24 07:00 | ALKERMES PLC: Q2 2024 Earnings Release |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
2024-07-28 | CRISPR THERAPEUTICS AG: Q2 2024 Earnings Release (Projected) |
Past sector events for Heron Therapeutics Inc
2024-07-17 02:00 | GENUS PLC: Q4 2024 Sales and Revenue Release - Trading Update |
2024-07-15 01:45 | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-10 03:01 | SUNMAX BIOTECHNOLOGY CO., LTD.: June 2024 Sales and Revenue Release |
2024-07-10 01:51 | POLARIS GROUP: June 2024 Sales and Revenue Release |
2024-06-11 03:04 | SUNMAX BIOTECHNOLOGY CO., LTD.: May 2024 Sales and Revenue Release |
2024-06-07 02:57 | POLARIS GROUP: May 2024 Sales and Revenue Release |
2024-05-29 16:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 17:14 | ALVOTECH: Q1 2024 Earnings Release |